File Download
  Patent History
  • Application
    EP 20090818741 2009-10-09
  • Publication
    EP 2342568 2011-07-13

published patent: CADHERIN-17 AS DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR LIVER CANCER

TitleCADHERIN-17 AS DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR LIVER CANCER
Priority Date2009-10-09 PCT/CN2009001117
2008-10-09 US 12/104038P
Inventors
Issue Date2011
Citation
EP Published Patent application EP 2342568. European Patent Office (EPO), Escapenet, 2011 How to Cite?
AbstractCompositions and methods for diagnosing, treating and/or preventing cancers characterized by CDH17 overexpression based on the detection of CDH17 or the use of CDH17 as a target for therapeutic intervention or prophylactic intervention are provided. Methods for diagnosing and/or monitoring liver cancers using the expressing of CDH17 involve detecting and/or quantitating the CDH17 protein or encoding nucleic acids (DNA or RNA) in a biological sample such as urine from the subject. Methods for treating liver cancers using CDH17 as a target and of sensitizing cells with aberrant expression of CDH17 have also been developed. The methods include suppression or knockdown of the expression of CDH17 by administering an effective amount of a CDH17 inhibitor.
Persistent Identifierhttp://hdl.handle.net/10722/176764
References

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:27Z-
dc.date.available2012-11-30T08:38:27Z-
dc.date.issued2011-
dc.identifier.citationEP Published Patent application EP 2342568. European Patent Office (EPO), Escapenet, 2011en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176764-
dc.description.abstractCompositions and methods for diagnosing, treating and/or preventing cancers characterized by CDH17 overexpression based on the detection of CDH17 or the use of CDH17 as a target for therapeutic intervention or prophylactic intervention are provided. Methods for diagnosing and/or monitoring liver cancers using the expressing of CDH17 involve detecting and/or quantitating the CDH17 protein or encoding nucleic acids (DNA or RNA) in a biological sample such as urine from the subject. Methods for treating liver cancers using CDH17 as a target and of sensitizing cells with aberrant expression of CDH17 have also been developed. The methods include suppression or knockdown of the expression of CDH17 by administering an effective amount of a CDH17 inhibitor.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleCADHERIN-17 AS DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR LIVER CANCERen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_version-
dc.contributor.inventorLuk, JMCen_HK
dc.contributor.inventorLee, Puiyue Nikkien_HK
dc.contributor.inventorLiu, Lingxiaoen_HK
dc.contributor.inventorPoon, RTPen_HK
dc.contributor.inventorFan, STen_HK
patents.identifier.applicationEP 20090818741en_HK
patents.description.assigneeUNIV HONG KONG [CN]en_HK
patents.description.countryEuropean Patent Officeen_HK
patents.date.publication2011-07-13en_HK
dc.relation.referencesWO 2007141280 (A2) 2007-12-13en_HK
dc.relation.referencesWO 2007141280 (A3) 2008-07-03en_HK
dc.relation.referencesUS 2007065859 (A1) 2007-03-22en_HK
dc.relation.referencesWO 9957149 (A3) 2000-03-02en_HK
dc.relation.referencesWO 9957149 (A2) 1999-11-11en_HK
dc.relation.referencesUS 2005002919 (A1) 2005-01-06en_HK
dc.relation.referencesWO 2009012773 (A1) 2009-01-29en_HK
dc.relation.referencesXP 002591718en_HK
dc.relation.referencesXP 004470763en_HK
dc.relation.referencesXP 008145831en_HK
dc.relation.referencesXP 008145829en_HK
dc.relation.referencesXP 008145832en_HK
dc.relation.referencesXP 004512473en_HK
dc.relation.referencesXP 019427607en_HK
dc.relation.referencesXP 019464776en_HK
dc.relation.referencesXP 008145837en_HK
patents.identifier.hkutechidSurg-2008-00285-2-
patents.identifier.hkutechidSurg-2008-00285-3-
patents.identifier.hkutechidSurg-2008-00285-4-
patents.identifier.hkutechidSurg-2008-00285-5-
patents.identifier.hkutechidSurg-2008-00285-6-
patents.date.application2009-10-09en_HK
patents.date.priority2009-10-09 PCT/CN2009001117en_HK
patents.date.priority2008-10-09 US 12/104038Pen_HK
patents.description.ccEPen_HK
patents.identifier.publicationEP 2342568en_HK
patents.relation.familyCN 102483414 (A) 2012-05-30en_HK
patents.relation.familyEP 2342568 (A1) 2011-07-13en_HK
patents.relation.familyUS 2010092978 (A1) 2010-04-15en_HK
patents.relation.familyWO 2010040277 (A1) 2010-04-15en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats